Onkologija is a distinguished open-access journal dedicated to the field of oncology, published by the Institute of Oncology Ljubljana. With its ISSN 1408-1741 and E-ISSN 1581-3215, this journal has become a crucial platform for researchers and healthcare professionals since its transition to open-access in 2008, allowing widespread dissemination of critical findings and innovations in cancer research and treatment. Located in Ljubljana, Slovenia, the journal aims to bridge the gap between clinical practice and research by publishing high-quality original articles, reviews, and case studies that address pivotal issues in oncology. Although specific metrics such as HIndex and Scopus ranks are currently unavailable, Onkologija’s commitment to advancing oncology knowledge is evident in its engaging publications that attract a diverse readership, making it an essential resource for anyone invested in the battle against cancer.

JNCI Cancer Spectrum, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of cancer research and oncology. With an impressive impact demonstrated through its Q1 ranking in both Cancer Research and Oncology categories for 2023, this journal provides a vital platform for disseminating high-quality research and innovative findings in a rapidly evolving landscape. Since its inception in 2017, JNCI Cancer Spectrum has embraced open access, enhancing the accessibility of evidence-based knowledge to researchers, professionals, and students across the globe. Additionally, it boasts notable positions in Scopus rankings, with a strong performance in both the Medicine and Biochemistry, Genetics and Molecular Biology categories. The journal is committed to its objectives of fostering collaborative efforts and encouraging dialogue among experts, making it an essential resource for anyone involved in cancer research.

Lung Cancer Management, published by FUTURE MEDICINE LTD, is a premier academic journal dedicated to the evolving field of oncology and respiratory medicine. With an ISSN of 1758-1966 and an E-ISSN of 1758-1974, this journal offers a platform for the dissemination of cutting-edge research, clinical studies, and expert reviews, all focusing on the latest advances in lung cancer treatment and management. Despite being a relatively new entry since its inception in 2014 and achieving its converged years from 2020 to 2024, it has already established itself in the Q3 quartile for both oncology and pulmonary and respiratory medicine as of 2023, according to category quartiles rankings. With a Scopus ranking of #98 in the category of Pulmonary and Respiratory Medicine and #266 in Oncology, the journal reflects a commitment to quality and relevance in its content. Although it does not offer open access, it remains a crucial resource for researchers, clinicians, and students seeking to stay informed about the latest developments and practical approaches in lung cancer management. The journal is accessible from its base in the United Kingdom, at UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ensuring that it caters to a global audience eager to explore and contribute to this vital field of medicine.

Welcome to the Journal of Palliative Medicine, a distinguished peer-reviewed publication dedicated to advancing the field of palliative care. Published by Mary Ann Liebert, Inc., this journal serves as a vital resource for researchers, healthcare professionals, and students in the disciplines of anesthesiology, nursing, and general medicine. With an impressive track record since its inception in 1998, the journal has achieved Q1 status in both Anesthesiology and Pain Medicine, as well as in Nursing (Miscellaneous), reflecting its scholarly impact within the academic community. The impact factor and rank underscore its significance, with the journal positioned at the 75th percentile in General Nursing and the 65th percentile in Anesthesiology and Pain Medicine according to Scopus rankings. Though the journal follows a subscription model, it remains committed to disseminating critical research that improves patient care and quality of life for those facing serious illnesses. As the field continues to evolve, the Journal of Palliative Medicine remains a cornerstone for fostering innovation and education in palliative practices, underscoring the importance of compassionate care.

The Journal of Hospice & Palliative Nursing (ISSN: 1522-2179, E-ISSN: 1539-0705), published by Lippincott Williams & Wilkins, stands as a leading resource in the field of hospice and palliative care nursing. With an impressive impact factor and ranked in the Q1 quartile for Advanced and Specialized Nursing and Q2 quartile for Community and Home Care as of 2023, this journal serves as a critical platform for disseminating evidence-based practices and innovative research. It covers a broad spectrum of topics, aiming to improve patient experiences and enhance the quality of care for individuals with life-limiting conditions. Created to support healthcare professionals, researchers, and students in the United States and beyond, the journal invites contributions that stimulate scholarly dialogue and advance the practice of palliative nursing. With publication years converging from 1999 to 2024, it remains an invaluable asset to the nursing community, fostering advancements in this vital area of healthcare.

ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.

JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, published by Taylor & Francis Inc, is a vital resource for professionals in the fields of anesthesiology, pain medicine, and pharmacology. With an ISSN of 1536-0288 and an E-ISSN of 1536-0539, this esteemed journal has been providing a platform for innovative research and critical reviews since its inception in 2002, and it will continue to contribute to scientific discourse until 2024. Holding a Q2 ranking in Anesthesiology and Pain Medicine and a Q3 ranking in Medical Pharmacology, the journal is positioned to deliver high-impact articles that explore advancements in pain management and palliative care strategies. While not an Open Access journal, it offers significant subscription-based access to its curated content, ensuring that researchers and practitioners have the opportunity to stay updated on the latest trends and findings in pain therapy. Furthermore, with its Scopus rankings reflecting ongoing relevance and a robust academic community, this journal is essential for those aiming to deepen their understanding of pain management pharmacotherapy.

Palliative Medicine is a premier journal dedicated to advancing the field of palliative care, published by SAGE Publications Ltd. Established in 1987 and continuing through 2024, this esteemed journal focuses on the integration of pain management and comprehensive care for patients with life-limiting illnesses. With its impressive impact factor and a prestigious Q1 ranking in both Anesthesiology and Pain Medicine, as well as in Medicine (miscellaneous), it stands as a critical resource for researchers, healthcare professionals, and students engaged in this vital area of medicine. The journal emphasizes original research, reviews, and clinical studies that contribute to the understanding and practice of palliative care, promoting improved quality of life and support for patients and their families. Although not open access, articles are accessible through institutional subscriptions, ensuring the dissemination of knowledge to a wide audience. Whether you are a seasoned researcher or an emerging professional in the field, Palliative Medicine remains an invaluable platform for scholarly exchange and innovation.

Onkologie is a peer-reviewed academic journal published by SPRINGER HEIDELBERG, focusing on the evolving fields of Oncology and Hematology. Established as a significant platform for the dissemination of research in these crucial areas of medicine, Onkologie aims to provide insights into the latest advancements, therapeutic strategies, and clinical practices that shape patient care in oncology and hematology. Despite its current placement in the Q4 category for both disciplines, this journal aspires to foster scholarly dialogues and enhance its contributions to the scientific community. The journal is based in Germany and encourages submissions that promote a deeper understanding of oncology's complex landscape, ensuring that researchers, clinicians, and students have access to a wealth of knowledge essential for clinical practice and further research. With an ISSN of 2731-7226 and E-ISSN of 2731-7234, Onkologie is committed to maintain high standards in publication and peer review, driving innovation and discovery in the fields it represents.

Medecine Palliative is a distinguished journal published by Elsevier, dedicated to the vital field of palliative care and pain management. With an ISSN of 1636-6522 and E-ISSN 2213-0098, this international journal has been an essential resource since its inception in 1970, currently covering research from 2004 to 2024. The journal reflects a commitment to enhancing the quality of life for patients facing serious illnesses, addressing critical issues in Anesthesiology and Oncology, while fostering innovative nursing practices in palliative care. While the journal holds a Q3 ranking in Anesthesiology and Pain Medicine and a Q4 in Oncology categories, making it a valuable venue for researchers and practitioners aiming to contribute to the evolving landscape of palliative medicine. Despite its lower rank in some categories, the journal serves as an important platform for insights, clinical findings, and current practices that can significantly impact patient care. Medecine Palliative is accessible to researchers, professionals, and students who are eager to explore the latest advancements and evidence-based approaches in end-of-life care.